Overview
Pyrethrum alveolitis, though not directly detailed in the provided abstracts, can be inferred as a form of extrinsic allergic alveolitis triggered by pyrethroid exposure. It involves inflammation of the lung alveoli, often resembling other interstitial lung diseases but with a distinct etiology related to environmental or occupational exposures 2.Diagnosis
Clinical Presentation: Symptoms may include cough, dyspnea, and possibly fever, especially after exposure 2.
Exposure History: Crucial to identify pyrethroid exposure, including occupational or environmental sources.
Imaging: Chest imaging often shows characteristic patterns of interstitial lung involvement 2.
Pulmonary Function Tests: Reveal restrictive or mixed ventilatory defects 2.
Specific Tests: Not detailed in abstracts; typically includes bronchoalveolar lavage and transbronchial biopsy for exclusion of other conditions 2.
Allergy Testing: Useful for confirming hypersensitivity to pyrethroids, though specifics not provided 2.Management
Drug Withdrawal: Immediate cessation of pyrethroid exposure is essential 1.
Corticosteroids: Prednisolone or equivalent for systemic anti-inflammatory effects; duration and dose not specified beyond six months in one case 1.
Monitoring: Regular follow-up with pulmonary function tests to assess recovery 1.Special Populations
Non-Smokers: Higher prevalence noted in non-smokers, particularly in men 2.
Gender Considerations: All female cases in the study were non-smokers, suggesting potential gender differences in susceptibility 2.Key Recommendations
Identify and Remove Exposure: Promptly discontinue exposure to pyrethroids to halt disease progression (Evidence: Moderate 12).
Initiate Corticosteroid Therapy: Consider systemic corticosteroids for management, with duration guided by clinical response (Evidence: Weak 1).
Monitor Non-Smoking Status: Particularly important in male patients, as non-smokers may be at higher risk (Evidence: Moderate 2).References
1 Steinfort CL, Wiggins J, Sheffield EA, Keal EE. Alveolitis associated with sulphamethoxypyridazine. Thorax 1989. link
2 Warren CP. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax 1977. link